Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evolus Inc | 14 | 0 | 0 | 0 | €5.65 | €20.71 | 266.602% |
| Vanda Pharmaceuticals | 13 | 0 | 2 | 0 | €4.64 | €17.30 | 272.879% |
| Pfizer Inc. | 15 | 2 | 2 | 0 | €22.35 | €27.95 | 25.075% |
| Incyte Corp. | 14 | 1 | 2 | 0 | €88.06 | €90.99 | 3.322% |
| Universal Health Services B | 13 | 0 | 2 | 0 | €199.00 | €218.17 | 9.632% |
| Xencor Inc. | 15 | 2 | 4 | 0 | €15.30 | €22.87 | 49.490% |
| WAVE Life Sciences Ltd | 14 | 1 | 2 | 0 | €6.45 | €16.43 | 154.651% |
| ProQR Therapeutics N.V. | 12 | 0 | 0 | 0 | €1.76 | €5.61 | 218.423% |
| Cytosorbents Corp. | 12 | 0 | 1 | 0 | €0.63 | €8.73 | 1290.048% |
| Quest Diagnostics Inc. | 12 | 0 | 0 | 0 | €156.75 | €173.26 | 10.531% |
| Nektar Therapeutics | 14 | 2 | 1 | 1 | €0.58 | €6.37 | 992.790% |
| Lightpath Techs A | 14 | 2 | 3 | 0 | €7.55 | €8.64 | 14.411% |
| SI-BONE Inc | 11 | 0 | 1 | 0 | €16.30 | €21.10 | 29.448% |
| Corcept Therapeutics Inc. | 11 | 0 | 1 | 0 | €73.94 | €124.85 | 68.856% |
| Henry Schein Inc. | 12 | 1 | 0 | 0 | €62.48 | €68.74 | 10.016% |
| Akebia Therapeutics Inc. | 12 | 1 | 2 | 0 | €1.35 | €6.16 | 358.016% |
| Sangamo Therapeutics Inc. | 12 | 1 | 0 | 0 | €0.43 | €8.60 | 1923.765% |
| Merck & Co. Inc. | 11 | 0 | 3 | 0 | €85.70 | €110.41 | 28.833% |
| EyePoint Pharmaceuticals Inc. | 11 | 0 | 1 | 0 | €12.10 | €23.84 | 96.988% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 6 | 0 | €24.00 | €43.63 | 81.773% |
| Pacira Pharmaceuticals | 10 | 0 | 3 | 0 | €20.20 | €29.38 | 45.441% |
| Xeris Biopharma Holdings Inc. | 10 | 0 | 2 | 0 | €5.78 | €7.56 | 30.971% |
| Bayer AG ADR | 10 | 0 | 1 | 0 | €8.40 | - | - |
| Becton, Dickinson & Co. | 10 | 0 | 1 | 0 | €166.50 | €219.37 | 31.753% |
| Akero Therapeutics Inc | 11 | 2 | 0 | 0 | €46.84 | €68.61 | 46.475% |